These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms. Lucero LM; Weltzin MM; Eaton JB; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P J Biol Chem; 2016 Jan; 291(5):2444-59. PubMed ID: 26644472 [TBL] [Abstract][Full Text] [Related]
15. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization. Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271 [TBL] [Abstract][Full Text] [Related]
16. The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype. Eaton JB; Lucero LM; Stratton H; Chang Y; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P J Pharmacol Exp Ther; 2014 Jan; 348(1):46-58. PubMed ID: 24190916 [TBL] [Abstract][Full Text] [Related]
17. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004 [TBL] [Abstract][Full Text] [Related]